A Multicenter, Randomized, Double-blind, Placebo-controlled Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects
Latest Information Update: 30 Apr 2025
At a glance
- Drugs Supaglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Yinnuo Pharmaceutical Technology
Most Recent Events
- 16 Apr 2025 New trial record